Disc Medicine Stock Buy Hold or Sell Recommendation

IRON Stock   64.96  1.45  2.28%   
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Disc Medicine is 'Hold'. The recommendation algorithm takes into account all of Disc Medicine's available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Disc Medicine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.
In addition, we conduct extensive research on individual companies such as Disc and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Execute Disc Medicine Buy or Sell Advice

The Disc recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Disc Medicine. Macroaxis does not own or have any residual interests in Disc Medicine or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Disc Medicine's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Disc MedicineBuy Disc Medicine
Hold

Market Performance

OKDetails

Volatility

Very steadyDetails

Hype Condition

Under hypedDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Disc Medicine has a Risk Adjusted Performance of 0.0935, Jensen Alpha of 0.3599, Total Risk Alpha of (0.09), Sortino Ratio of 0.1306 and Treynor Ratio of 0.487
Macroaxis provides unbiased investment recommendation on Disc Medicine that should be used to complement current analysts and expert consensus on Disc Medicine. Our trade advice engine determines the company's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. To make sure Disc Medicine is not overpriced, please confirm all Disc Medicine fundamentals, including its price to book, cash flow from operations, as well as the relationship between the Cash Flow From Operations and market capitalization . Given that Disc Medicine has a shares owned by institutions of 97.73 %, we urge you to verify Disc Medicine market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Disc Medicine Trading Alerts and Improvement Suggestions

Disc Medicine had very high historical volatility over the last 90 days
Net Loss for the year was (76.43 M) with profit before overhead, payroll, taxes, and interest of 0.
Disc Medicine generates negative cash flow from operations
Disc Medicine has a frail financial position based on the latest SEC disclosures
Over 98.0% of the company shares are owned by institutional investors
Latest headline from investing.com: Disc Medicine chief medical officer sells 546,152 in stock

Disc Medicine Returns Distribution Density

The distribution of Disc Medicine's historical returns is an attempt to chart the uncertainty of Disc Medicine's future price movements. The chart of the probability distribution of Disc Medicine daily returns describes the distribution of returns around its average expected value. We use Disc Medicine price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Disc Medicine returns is essential to provide solid investment advice for Disc Medicine.
Mean Return
0.46
Value At Risk
-4.25
Potential Upside
5.21
Standard Deviation
4.13
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Disc Medicine historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Disc Medicine Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Disc Medicine or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Disc Medicine's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Disc stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.36
β
Beta against Dow Jones0.93
σ
Overall volatility
4.20
Ir
Information ratio 0.09

Disc Medicine Volatility Alert

Disc Medicine currently demonstrates below-average downside deviation. It has Information Ratio of 0.09 and Jensen Alpha of 0.36. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Disc Medicine's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Disc Medicine's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Disc Medicine Fundamentals Vs Peers

Comparing Disc Medicine's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Disc Medicine's direct or indirect competition across all of the common fundamentals between Disc Medicine and the related equities. This way, we can detect undervalued stocks with similar characteristics as Disc Medicine or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Disc Medicine's fundamental indicators could also be used in its relative valuation, which is a method of valuing Disc Medicine by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Disc Medicine to competition
FundamentalsDisc MedicinePeer Average
Return On Equity-0.25-0.31
Return On Asset-0.18-0.14
Current Valuation1.4 B16.62 B
Shares Outstanding29.76 M571.82 M
Shares Owned By Insiders12.47 %10.09 %
Shares Owned By Institutions97.73 %39.21 %
Number Of Shares Shorted1.63 M4.71 M
Price To Book4.04 X9.51 X
EBITDA(91.03 M)3.9 B
Net Income(76.43 M)570.98 M
Total Debt2.1 M5.32 B
Book Value Per Share15.73 X1.93 K
Cash Flow From Operations(73.46 M)971.22 M
Short Ratio6.00 X4.00 X
Earnings Per Share(3.95) X3.12 X
Target Price92.75
Number Of Employees8218.84 K
Market Capitalization1.89 B19.03 B
Total Asset368 M29.47 B
Retained Earnings(188.65 M)9.33 B
Working Capital344.22 M1.48 B
Net Asset368 M
Note: Disposition of 1500 shares by Savage William Jacob of Disc Medicine at 47.41 subject to Rule 16b-3 [view details]

Disc Medicine Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Disc . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Disc Medicine Buy or Sell Advice

When is the right time to buy or sell Disc Medicine? Buying financial instruments such as Disc Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Disc Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Energy Funds Thematic Idea Now

Energy Funds
Energy Funds Theme
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock:
Check out Disc Medicine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.95)
Return On Assets
(0.18)
Return On Equity
(0.25)
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.